Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells - PubMed (original) (raw)
. 2008 Nov;38(11):2981-92.
doi: 10.1002/eji.200838761.
Affiliations
- PMID: 18924132
- DOI: 10.1002/eji.200838761
Free article
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Frank Schmitz et al. Eur J Immunol. 2008 Nov.
Free article
Abstract
The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.
Similar articles
- The TSC-mTOR signaling pathway regulates the innate inflammatory response.
Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, Stuhlmeier KM, Kolbe T, Stulnig TM, Hörl WH, Hengstschläger M, Müller M, Säemann MD. Weichhart T, et al. Immunity. 2008 Oct 17;29(4):565-77. doi: 10.1016/j.immuni.2008.08.012. Epub 2008 Oct 9. Immunity. 2008. PMID: 18848473 - The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
Weichhart T, Säemann MD. Weichhart T, et al. Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii70-4. doi: 10.1136/ard.2008.098459. Ann Rheum Dis. 2008. PMID: 19022819 Review. - IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O, Almazan G. Bibollet-Bahena O, et al. J Neurochem. 2009 Jun;109(5):1440-51. doi: 10.1111/j.1471-4159.2009.06071.x. Epub 2009 Mar 28. J Neurochem. 2009. PMID: 19453943 - Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M, Kurian SM, Lin S, Borodyanskiy A, Zhang Z, Li Z, Kim SJ, Salomon DR, Abecassis M. Hummel M, et al. Transplantation. 2009 Jan 27;87(2):178-88. doi: 10.1097/TP.0b013e3181938971. Transplantation. 2009. PMID: 19155971 - The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.
O'Neill LA. O'Neill LA. Immunol Rev. 2008 Dec;226:10-8. doi: 10.1111/j.1600-065X.2008.00701.x. Immunol Rev. 2008. PMID: 19161412 Review.
Cited by
- The role of tuberous sclerosis complex 1 in regulating innate immunity.
Pan H, O'Brien TF, Zhang P, Zhong XP. Pan H, et al. J Immunol. 2012 Apr 15;188(8):3658-66. doi: 10.4049/jimmunol.1102187. Epub 2012 Mar 12. J Immunol. 2012. PMID: 22412198 Free PMC article. - The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
Da M, Chen L, Enk A, Ring S, Mahnke K. Da M, et al. Front Immunol. 2022 May 31;13:914799. doi: 10.3389/fimmu.2022.914799. eCollection 2022. Front Immunol. 2022. PMID: 35711418 Free PMC article. Review. - The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism.
Fensterheim BA, Young JD, Luan L, Kleinbard RR, Stothers CL, Patil NK, McAtee-Pereira AG, Guo Y, Trenary I, Hernandez A, Fults JB, Williams DL, Sherwood ER, Bohannon JK. Fensterheim BA, et al. J Immunol. 2018 Jun 1;200(11):3777-3789. doi: 10.4049/jimmunol.1800085. Epub 2018 Apr 23. J Immunol. 2018. PMID: 29686054 Free PMC article. - Porphyromonas gingivalis Outer Membrane Vesicles Induce Selective Tumor Necrosis Factor Tolerance in a Toll-Like Receptor 4- and mTOR-Dependent Manner.
Waller T, Kesper L, Hirschfeld J, Dommisch H, Kölpin J, Oldenburg J, Uebele J, Hoerauf A, Deschner J, Jepsen S, Bekeredjian-Ding I. Waller T, et al. Infect Immun. 2016 Mar 24;84(4):1194-1204. doi: 10.1128/IAI.01390-15. Print 2016 Apr. Infect Immun. 2016. PMID: 26857578 Free PMC article. - Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.
Kim C, Rockenstein E, Spencer B, Kim HK, Adame A, Trejo M, Stafa K, Lee HJ, Lee SJ, Masliah E. Kim C, et al. Cell Rep. 2015 Oct 27;13(4):771-782. doi: 10.1016/j.celrep.2015.09.044. Epub 2015 Oct 17. Cell Rep. 2015. PMID: 26489461 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous